Clinical Trials Logo

Healthy Adults clinical trials

View clinical trials related to Healthy Adults.

Filter by:

NCT ID: NCT03319134 Completed - Healthy Adults Clinical Trials

Investigating the Neural Correlates in Memory Retrieval After HD-tDCS

Start date: September 18, 2017
Phase: N/A
Study type: Interventional

The overall objective of this study is to investigate the neural correlate in retrieval memory task. The aim of the study is to understand the undergoing changes in late positive ERP component during retrieval memory task when stimulating the posterior cingulate cortex (PCC) with High Definition Transcranial Direct Current Stimulation (HD-tDCS).

NCT ID: NCT03312699 Completed - Influenza Clinical Trials

Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort

SLVP033
Start date: September 19, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to use an existing, unique clinical cohort: the longitudinal cohort of younger (21-40 years) and elderly (>65 years) subjects whose yearly influenza vaccine responses have been studied extensively since 2007, to gain molecular and cellular mechanistic insights into the impaired vaccine responses in the elderly.

NCT ID: NCT03309072 Completed - Healthy Adults Clinical Trials

Investigating Accelerated Learning and Memory in Healthy Subjects Using a Face Name Memory Task

Start date: September 27, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether we can accelerate learning and improve associative memory performance in healthy subjects by applying transcranial Direct Current Stimulation (tDCS) during a Face Name memory task.

NCT ID: NCT03289832 Completed - Healthy Adults Clinical Trials

Effect of Orally Delivered Phytochemicals on Aging and Inflammation in the Skin

Start date: September 25, 2017
Phase: N/A
Study type: Interventional

The objective is to determine, in a small number of participants, the protective effects of UV-induced skin erythema (reddening or "sunburn") following oral administration of sulforaphane, curcumin, or a combination of the two plant (diet)-based supplements. The investigators will be using the over-the-counter nutritional supplements Crucera-SGS and Meriva-SF to deliver the biologically stable sulforaphane precursor and a highly bioavailable formulation of curcumin. Volunteers will be challenged with UV irradiation at 2-times the minimum erythematous dose (M.E.D.) on discrete 2 cm diameter circles on the upper buttocks. Skin redness will be monitored daily using a chromometer. Biomarkers will then be evaluated in blood, urine, and skin biopsies.

NCT ID: NCT03278535 Completed - Healthy Volunteers Clinical Trials

Reference Gait Data for Healthy Subjects

Start date: July 4, 2017
Phase:
Study type: Observational

Three dimensional gait analysis is widely accepted as a general measure of functional ability among individuals as it is related to health, well-being and quality of life. To diagnose subtle changes/deviations in gait and to correctly interpret gait, a reference gait database of healthy subjects is required. Computer Assisted Rehabilitation Environment (Caren) is a new gait analysis system which combines the 3D motion captures system with a split belt force plate instrumented treadmill and a virtual reality environment. This system enables to analyses several successive steps, which is impossible in the standard overground laboratories. Until now, no reference gait database has been created using the Caren system. The aim of this descriptive study is to create a reference database of gait in healthy adults with varying subject characteristics using Caren. This study is a single center descriptive study to build a reference database on gait of healthy adults of different ages. Six age groups are composed existing of 20 males and 20 females. Taken into account that 10% of the volunteers (especially elderly) may drop out due to e.g. disability, a total of 264 subjects will be recruited to ensure that database will include 240 subjects. Inclusion criteria: ambulatory, ability to walk without aid for 30 minutes, age older than 18 years and willing to participate. Exclusion criteria: muscular skeletal, cardiopulmonary disorders or other diseases significantly influencing gait. Medical interventions, such as surgical treatment or botulinium toxin 6 months, which significantly influence gait. Subjects will walk at different walking speeds at Caren while gait is measured. Subjects always wear a safety harness to avoid falling. In addition adults wear standard shoes (gymnastic booties) provided by the lab to avoid shoes effects. All subjects undergo measurement of leg length, body length and body weight in order to retrieve anthropometric parameters. In addition a standard physical examination is performed to get information about a subjects' muscle strength, balance and articular mobility of the hip, knee and ankle. Gait kinematic, kinetic, spatio-temporal and balance parameters are measured.

NCT ID: NCT03276637 Completed - Healthy Adults Clinical Trials

Enabling Personalized Medicine Through Exome Sequencing in the U.S. Air Force

MilSeq
Start date: August 23, 2017
Phase: N/A
Study type: Interventional

The MilSeq Project is a nonrandomized, prospective pilot study of whole exome sequencing (WES) in the U.S. Air Force. The purpose of this study is to explore the implementation of WES into clinical medical care in the military health system.

NCT ID: NCT03228693 Completed - Healthy Adults Clinical Trials

Gene Expression and Biomarker Profiling of Keloid Skin

Start date: September 11, 2017
Phase: N/A
Study type: Interventional

This study aims to examine both the genetic profile and the biomarkers implicated in keloid scar formation. Hypothesis: 1. Differences in the genetic profiles of lesional and non-lesional skin contribute a given population's propensity to develop keloids 2. Differences in biomolecules expressed in subjects with and without keloids can help predict keloid occurrence and severity 3. Biomarker analysis will provide useful insights for future targeted therapies for keloid scars

NCT ID: NCT03191513 Completed - Healthy Adults Clinical Trials

The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Fat Metabolism

INTERMET
Start date: June 12, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether there are differences in postprandial metabolic indices following interesterified fats used commercially versus the corresponding un-interesterified blend.

NCT ID: NCT03168022 Completed - Healthy Adults Clinical Trials

Bioequivalence Study of TNX-102 SL 2.8 mg Sublingual Tablets From Two Manufacturers.

Start date: December 16, 2015
Phase: Phase 1
Study type: Interventional

This study is an open-label, 2-way crossover, single-dose study that is being performed to establish the bioequivalence of TNX-102 SL 2.8 mg tablets from two manufacturers: manufacturer of the Phase 2/3 drug product and manufacturer of the Phase 3 and commercial drug product. This bioequivalence study will confirm (1) the drug product manufactured from these two manufacturers are therapeutically equivalent and (2) the efficacy and safety data obtained in clinical studies using TNX-102 SL from these two manufacturers are comparable.

NCT ID: NCT03161418 Completed - Healthy Adults Clinical Trials

Study of the Safety of KSP Heptapeptide (KSP-910638G)

Start date: June 21, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety of orally administered KSP-910638G, a topically administered li-cor IRDye800CW labeled heptapeptide specific for human epithelial growth factor receptor 2 (HER2).